To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.

中文翻译：

---

2018年，加拿大急诊医院的高危念珠菌患病率。

为了确定在加拿大人中可能存在定植风险的金黄色葡萄球菌的患病率，我们筛选了488例在国外住院，患有碳青霉烯酶生产菌（CPO）或抗真菌药使用率较高的患者。2例患者定植有金黄色葡萄球菌。他们俩都在印度接受了医疗保健并拥有了CPO。在印度次大陆最近接受医疗保健且被CPO定植或感染的35例患者中，耳形梭菌的患病率为5.7％。